Company page

Longbio Pharma (suzhou) Co., Ltd. Class H

Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 876.77 million. The company focuses on the development and commercialization of innovative pharmaceutical products. Longbio Pharma aims to address unmet medical needs through its research and development efforts.